Securities code: Shandong Weigao Orthopaedic Device Co.Ltd(688161) securities abbreviation: Shandong Weigao Orthopaedic Device Co.Ltd(688161) Announcement No.: 2022008 Shandong Weigao Orthopaedic Device Co.Ltd(688161)
Announcement on correction of 2021 annual report and summary
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Shandong Weigao Orthopaedic Device Co.Ltd(688161) (hereinafter referred to as “the company”) was published on China Securities Journal, Shanghai Securities News, securities times, securities daily and the website of Shanghai Stock Exchange (www.sse. Com. CN.) on March 30, 2022 The annual report of 2021 and its abstract were disclosed on the. After verification, it is found that some contents in the 2021 annual report and summary are incorrect, which is hereby corrected.
This correction does not involve the company’s main business, does not affect the balance sheet, income statement, does not affect the net amount of financing activities in the cash flow statement, and will not have a significant impact on the company’s performance in 2021. The specific corrections are as follows: I. corrections
(I) important tips
Before correction:
“As of December 31, 2021, the total share capital of the company is 400000000 shares, and the total cash dividend to be distributed is 2080000 yuan (including tax)” in “VII. Profit distribution plan or plan for conversion of reserve fund into share capital in the reporting period adopted by the board of directors in the” 2021 annual report “and” important tips “in the abstract.
After correction:
“As of December 31, 2021, the total share capital of the company is 400000000 shares, and the total cash dividend to be distributed is 208000000 yuan (including tax)” in “VII. Profit distribution plan or plan for conversion of reserve fund into share capital during the reporting period adopted by the board of directors in the” 2021 annual report “and” important tips “in the abstract.
(II) corporate governance
Before correction:
“XII. Profit distribution or capital reserve transferred to increase reserves” in “section IV corporate governance” of the 2021 Annual Report
“As of December 31, 2021, the total share capital of the company is 400000000 shares, which is calculated to pay a total cash dividend of 2080000 yuan (including tax)”.
After correction:
“As of December 31, 2021, the total share capital of the company is 400000000 shares, which is calculated as a total cash dividend of 208000000 yuan (including tax)” in “XII. Profit distribution or capital reserve conversion plan” in “section IV corporate governance” of the 2021 annual report.
2、 Other instructions
In addition to the above corrections, other contents of the company’s relevant periodic reports remain unchanged.
The corrected relevant periodic reports are disclosed on the website of Shanghai Stock Exchange (www.sse. Com. CN) on the same day as this announcement, For investors to consult. The Company Apologizes for the inconvenience caused to the majority of investors by this correction.
It is hereby announced.
Shandong Weigao Orthopaedic Device Co.Ltd(688161) board of directors March 30, 2022
